ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` ~ Table 2 x V E Strategy 1. Treatment eligibility: risk and hypertension based4 Strategy 2. Treatment eligibility: risk based Reference scenario KSHI Framing-ham KSHI Rapso-maniki KSHI Lawes
Stroke events 241 232 233 221 234 235 225
CHD events 416 408 404 392 410 407 398% DALYs averted (from events prevented) reference 130 142 342 95 106 259 DALYs lost (due to treatment) 80 81 33 34 NET DALYs averted 50 62 261 73 226 Total costs 607,608 996,082 995,255 973,734 790,766 789,974 772,617 Screening Costs 0 47,400 Hypertension treatment costs 293,674 293,893 296,196 121,395 121,595 122,775- Above-service delivery costs for KSHI program 63,453 63,500 63,998 26,229 26,273 26,527 Care after CVD event costs 591,555 590,462 566,141 595,741 594,707 575,9156 Reduction in acute and follow-up costs after CVD event 2.6% 2.8% 6.8% 2.0% 2.1% 5.2% % of total costs related to KSHI intervention* 0% 36% 25% 27%
d MbP?_ % * + &P &F